Donald Morton

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Anatomy

Lymph Nodes

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Faries Mark B; Hsueh Eddy C; Ye Xing; Hoban Mary; Morton Donald L
Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine.
Lee Jonathan H; Gulec Seza A; Kyshtoobayeva Ainura; Sim Myung-Shin; Morton Donald L
Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma.
Narita N; Tanemura A; Murali R; Scolyer R A; Huang S; Arigami T; Yanagita S; Chong K K; Thompson J F; Morton D L; Hoon D S
Functional RET G691S polymorphism in cutaneous malignant melanoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Donald Morton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Faries Mark B; Hsueh Eddy C; Ye Xing; Hoban Mary; Morton Donald L
Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):7029-35.
2009: Lee Jonathan H; Gulec Seza A; Kyshtoobayeva Ainura; Sim Myung-Shin; Morton Donald L
Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma.
Annals of surgical oncology 2009;16(10):2834-9.
2009: Narita N; Tanemura A; Murali R; Scolyer R A; Huang S; Arigami T; Yanagita S; Chong K K; Thompson J F; Morton D L; Hoon D S
Functional RET G691S polymorphism in cutaneous malignant melanoma.
Oncogene 2009;28(34):3058-68.
2009: Lee Chris C; Faries Mark B; Wanek Leslie A; Morton Donald L
Improved survival for stage IV melanoma from an unknown primary site.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(21):3489-95.
2009: Conway W Charles; Faries Mark B; Nicholl Michael B; Terando Alicia M; Glass Edwin C; Sim MyungShin; Morton Donald L
Age-related lymphatic dysfunction in melanoma patients.
Annals of surgical oncology 2009;16(6):1548-52.
2009: Lee Chris C; Faries Mark B; Ye Xing; Morton Donald L
Solitary dermal melanoma: beginning or end of the metastatic process?
Annals of surgical oncology 2009;16(3):578-84.
2008: Goto Yasufumi; Arigami Takaaki; Kitago Minoru; Nguyen Sandy L; Narita Norihiko; Ferrone Soldano; Morton Donald L; Irie Reiko F; Hoon Dave S B
Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors.
Molecular cancer therapeutics 2008;7(11):3642-53.
2008: Wright Byron E; Scheri Randall P; Ye Xing; Faries Mark B; Turner Roderick R; Essner Richard; Morton Donald L
Importance of sentinel lymph node biopsy in patients with thin melanoma.
Archives of surgery (Chicago, Ill. : 1960) 2008;143(9):892-9; discussion 899-900.
2008: Morton Donald L; Cochran Alistair J; Thompson John F
The rationale for sentinel-node biopsy in primary melanoma.
Nature clinical practice. Oncology 2008;5(9):510-1.
2008: Goto Yasufumi; Ferrone Soldano; Arigami Takaaki; Kitago Minoru; Tanemura Atsushi; Sunami Eiji; Nguyen Sandy L; Turner Roderick R; Morton Donald L; Hoon Dave S B
Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3401-7.
2008: Lee Chris C; Faries Mark B; Wanek Leslie A; Morton Donald L
Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):535-41.
2007: Faries Mark B; Morton Donald L
Surgery and sentinel lymph node biopsy.
Seminars in oncology 2007;34(6):498-508.
2007: Torisu-Itakura Hitoe; Lee Jonathan H; Huynh Young; Ye Xing; Essner Richard; Morton Donald L
Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(8):831-8.
2007: Bilchik Anton J; Hoon Dave S B; Saha Sukamal; Turner Roderick R; Wiese David; DiNome Maggie; Koyanagi Kazuo; McCarter Martin; Shen Perry; Iddings Douglas; Chen Steven L; Gonzalez Maria; Elashoff David; Morton Donald L
Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Annals of surgery 2007;246(4):568-75; discussion 575-7.
2007: Scheri Randall P; Essner Richard; Turner Roderick R; Ye Xing; Morton Donald L
Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
Annals of surgical oncology 2007;14(10):2861-6.
2007: Terando Alicia M; Faries Mark B; Morton Donald L
Vaccine therapy for melanoma: current status and future directions.
Vaccine 2007;25 Suppl 2():B4-16.
2007: Morton Donald L; Scheri Randall P; Balch Charles M
Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?
Annals of surgical oncology 2007;14(9):2437-9.
2007: Faries Mark B; Gupta Rishab K; Ye Xing; Lee Christopher; Yee Reynold; Leopoldo Zacharias; Essner Richard; Foshag Leland J; Elashoff David; Morton Donald L
A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients.
Cancer investigation 2007;25(5):285-93.
2007: Ravindranath Mepur H; Muthugounder Sakunthala; Hannah Maghasi R; Morton Donald L
Significance of endogenous augmentation of antiganglioside IgM in cancer patients: potential tool for early detection and management of cancer therapy.
Annals of the New York Academy of Sciences 2007;1107():212-22.
2007: Torisu-Itakura Hitoe; Lee Jonathan H; Scheri Randall P; Huynh Young; Ye Xing; Essner Richard; Morton Donald L
Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3125-32.
2007: Zogakis Theresa G; Essner Richard; Wang He-jing; Foshag Leland J; Morton Donald L
Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
Annals of surgical oncology 2007;14(5):1604-11.
2007: Ravindranath Mepur H; Yesowitch Paul; Sumobay Cindy; Morton Donald L
Glycoimmunomics of human cancer: current concepts and future perspectives.
Future oncology (London, England) 2007;3(2):201-14.
2007: Ravindranath Mepur H; Muthugounder Sakunthala; Presser Naftali; Selvan Senthamil R; Santin Alessandro D; Bellone Stefania; Saravanan Thiruverkadu S; Morton Donald L
Immunogenic gangliosides in human ovarian carcinoma.
Biochemical and biophysical research communications 2007;353(2):251-8.
2007: Amersi Farin; Morton Donald L
The role of sentinel lymph node biopsy in the management of melanoma.
Advances in surgery 2007;41():241-56.
2006: Morton Donald L; Thompson John F; Cochran Alistair J; Mozzillo Nicola; Elashoff Robert; Essner Richard; Nieweg Omgo E; Roses Daniel F; Hoekstra Harald J; Karakousis Constantine P; Reintgen Douglas S; Coventry Brendon J; Glass Edwin C; Wang He-Jing;
Sentinel-node biopsy or nodal observation in melanoma.
The New England journal of medicine 2006;355(13):1307-17.
2006: Essner Richard; Scheri Randall; Kavanagh Maihgan; Torisu-Itakura Hitoe; Wanek Leslie A; Morton Donald L
Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
Archives of surgery (Chicago, Ill. : 1960) 2006;141(9):877-82; discussion 882-4.
2006: Mori Takuji; Martinez Steve R; O'Day Steven J; Morton Donald L; Umetani Naoyuki; Kitago Minoru; Tanemura Atsushi; Nguyen Sandy L; Tran Andy N; Wang He-Jing; Hoon Dave S B
Estrogen receptor-alpha methylation predicts melanoma progression.
Cancer research 2006;66(13):6692-8.
2006: Kim Joseph; Mori Takuji; Chen Steven L; Amersi Farin F; Martinez Steve R; Kuo Christine; Turner Roderick R; Ye Xing; Bilchik Anton J; Morton Donald L; Hoon Dave S B
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
Annals of surgery 2006;244(1):113-20.
2006: Bilchik Anton J; DiNome Maggie; Saha Sukamal; Turner Roderick R; Wiese David; McCarter Martin; Hoon Dave S B; Morton Donald L
Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
Archives of surgery (Chicago, Ill. : 1960) 2006;141(6):527-33; discussion 533-4.
2006: Young Shawn E; Martinez Steve R; Faries Mark B; Essner Richard; Wanek Leslie A; Morton Donald L
Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes?
Cancer journal (Sudbury, Mass.) 2006;12(3):207-11.
2006: Koyanagi Kazuo; O'Day Steven J; Gonzalez Rene; Lewis Karl; Robinson William A; Amatruda Thomas T; Kuo Christine; Wang He-Jing; Milford Robert; Morton Donald L; Hoon Dave S B
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1137-43.
2005: Takeuchi Hiroya; Morton Donald L; Elashoff David; Hoon Dave S B
Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.
International journal of cancer. Journal international du cancer 2005;117(6):1032-8.
2005: Zogakis Theresa G; Essner Richard; Wang He-jing; Turner Roderick R; Takasumi Yuki T; Gaffney Robin L; Lee Jonathan H; Morton Donald L
Melanoma recurrence patterns after negative sentinel lymphadenectomy.
Archives of surgery (Chicago, Ill. : 1960) 2005;140(9):865-71; discussion 871-2.
2005: Morton Donald L; Cochran Alistair J; Thompson John F; Elashoff Robert; Essner Richard; Glass Edwin C; Mozzillo Nicola; Nieweg Omgo E; Roses Daniel F; Hoekstra Harald J; Karakousis Constantine P; Reintgen Douglas S; Coventry Brendon J; Wang He-jing;
Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
Annals of surgery 2005;242(3):302-11; discussion 311-3.
2005: Ravindranath Mepur H; Muthugounder Sakunthala; Presser Naftali; Ye Xing; Brosman Stanley; Morton Donald L
Endogenous immune response to gangliosides in patients with confined prostate cancer.
International journal of cancer. Journal international du cancer 2005;116(3):368-77.
2005: Kang John C; Wanek Leslie A; Essner Richard; Faries Mark B; Foshag Leland J; Morton Donald L
Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(21):4764-70.
2005: Ravindranath Mepur H; Muthugounder Sakunthala; Saravanan Thiruverkadu S; Presser Naftali; Morton Donald L
Human antiganglioside autoantibodies: validation of ELISA.
Annals of the New York Academy of Sciences 2005;1050():229-42.
2005: Lee Jonathan H; Torisu-Itakara Hitoe; Cochran Alistair J; Kadison Alan; Huynh Young; Morton Donald L; Essner Richard
Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):107-12.
2005: Faries Mark B; Morton Donald L
Therapeutic vaccines for melanoma: current status.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2005;19(4):247-60.
2004: Ravindranath Mepur H; Muthugounder Sakunthala; Presser Naftali; Selvan Senthamil R; Portoukalian Jacques; Brosman Stanley; Morton Donald L
Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer.
Biochemical and biophysical research communications 2004;324(1):154-65.
2004: Hsueh Eddy C; Famatiga Estela; Shu Sherry; Ye Xing; Morton Donald L
Peripheral blood CD4+ T-cell response before postoperative active immunotherapy correlates with clinical outcome in metastatic melanoma.
Annals of surgical oncology 2004;11(10):892-9.
2004: Essner Richard; Lee Jonathan H; Wanek Leslie A; Itakura Hitoe; Morton Donald L
Contemporary surgical treatment of advanced-stage melanoma.
Archives of surgery (Chicago, Ill. : 1960) 2004;139(9):961-6; discussion 966-7.
2004: Lee Jonathan H; Essner Richard; Torisu-Itakura Hitoe; Wanek Leslie; Wang Hejing; Morton Donald L
Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3677-84.
2004: Faries Mark B; Bleicher Richard J; Ye Xing; Essner Richard; Morton Donald L
Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms.
Archives of surgery (Chicago, Ill. : 1960) 2004;139(8):870-6; discussion 876-7.
2004: Takeuchi Hiroya; Morton Donald L; Kuo Christine; Turner Roderick R; Elashoff David; Elashoff Robert; Taback Bret; Fujimoto Akihide; Hoon Dave S B
Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2671-80.
2004: Wilson Lori L; Tran Linh; Morton Donald L; Hoon Dave S B
Detection of differentially expressed proteins in early-stage melanoma patients using SELDI-TOF mass spectrometry.
Annals of the New York Academy of Sciences 2004;1022():317-22.
2004: Hoon Dave S B; Spugnardi Mia; Kuo Christine; Huang Sharon K; Morton Donald L; Taback Bret
Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
Oncogene 2004;23(22):4014-22.
2004: Fujimoto Akihide; Takeuchi Hiroya; Taback Bret; Hsueh Eddy C; Elashoff David; Morton Donald L; Hoon Dave S B
Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma.
Cancer research 2004;64(6):2245-50.
2004: Morton Donald L
Sentinel node mapping and an International Sentinel Node Society: current issues and future directions.
Annals of surgical oncology 2004;11(3 Suppl):137S-43S.
2004: Faries Mark B; Gupta Rishab K; Ye Xing; Hsueh Eddy C; Morton Donald L
Melanoma-inhibiting activity assay predicts survival in patients receiving a therapeutic cancer vaccine after complete resection of American Joint Committee on Cancer Stage III Melanoma.
Annals of surgical oncology 2004;11(1):85-93.
2004: Litvak David A; Gupta Rishab K; Yee Reynold; Wanek Leslie A; Ye Wei; Morton Donald L
Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors.
Journal of the American College of Surgeons 2004;198(1):27-35.
2004: Hsueh Eddy C; Essner Richard; Foshag Leland J; Ye Xing; Wang He-Jing; Morton Donald L
Prolonged survival after complete resection of metastases from intraocular melanoma.
Cancer 2004;100(1):122-9.
2003: Hsueh Eddy C; Morton Donald L
Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine.
Seminars in cancer biology 2003;13(6):401-7.
2003: Gulec Seza A; Faries Mark B; Lee Chris C; Kirgan Daniel; Glass C; Morton Donald L; Essner Richard
The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making.
Clinical nuclear medicine 2003;28(12):961-5.
2003: Yao Katharine A; Hsueh Eddy C; Essner Richard; Foshag Leland J; Wanek Leslie A; Morton Donald L
Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?
Annals of surgery 2003;238(5):743-7.
2003: Trocha Steven D; Saha Sukamal S; Wiese David; Thompson Jim; Morton Donald L; Bilchik Anton J
Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment.
The American surgeon 2003;69(10):918-22.
2003: Morton Donald L; Hoon Dave S B; Cochran Alistair J; Turner Roderick R; Essner Richard; Takeuchi Hiroya; Wanek Leslie A; Glass Edwin; Foshag Leland J; Hsueh Eddy C; Bilchik Anton J; Elashoff David; Elashoff Robert
Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.
Annals of surgery 2003;238(4):538-49; discussion 549-50.
2003: Kuo Christine T; Hoon Dave S B; Takeuchi Hiroya; Turner Roderick; Wang He-Jing; Morton Donald L; Taback Bret
Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3566-72.
2003: Wascher Robert A; Morton Donald L; Kuo Christine; Elashoff Robert M; Wang He-Jing; Gerami Mehri; Hoon Dave S B
Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with a melanoma vaccine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2558-63.
2003: Ravindranath Mepur H; Hsueh Eddy C; Verma Meena; Ye Wei; Morton Donald L
Serum total ganglioside level correlates with clinical course in melanoma patients after immunotherapy with therapeutic cancer vaccine.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(3):277-85.
2003: Hsueh Eddy C; Gupta Rishab K; Lefor Alan; Reyzin Gary; Ye Wei; Morton Donald L
Androgen blockade enhances response to melanoma vaccine.
The Journal of surgical research 2003;110(2):393-8.
2003: Kadison Alan S; Morton Donald L
Immunotherapy of malignant melanoma.
The Surgical clinics of North America 2003;83(2):343-70.
2003: Bleicher Richard J; Essner Richard; Foshag Leland J; Wanek Leslie A; Morton Donald L
Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1326-31.
2003: Trocha Steven D; Nora Dean T; Saha Sukamal S; Morton Donald L; Wiese David; Bilchik Anton J
Combination probe and dye-directed lymphatic mapping detects micrometastases in early colorectal cancer.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(3):340-5; discussion 345-6.
2003: Bilchik Anton J; Nora Dean T; Sobin Leslie H; Turner Roderick R; Trocha Steven; Krasne David; Morton Donald L
Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(4):668-72.
2003: Chung Mathew H; Gupta Rishab K; Hsueh Eddy; Essner Richard; Ye Wei; Yee Reynold; Morton Donald L
Humoral immune response to a therapeutic polyvalent cancer vaccine after complete resection of thick primary melanoma and sentinel lymphadenectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):313-9.
2003: Faries Mark B; Morton Donald L
Melanoma: is immunotherapy of benefit?
Advances in surgery 2003;37():139-69.
2002: Bilchik Anton J; Nora Dean T; Saha Sukamal; Turner Roderick; Wiese David; Kuo Christine; Ye Xing; Morton Donald L; Hoon Dave S B
The use of molecular profiling of early colorectal cancer to predict micrometastases.
Archives of surgery (Chicago, Ill. : 1960) 2002;137(12):1377-83.
2002: Hsueh Eddy C; Essner Richard; Foshag Leland J; Ollila David W; Gammon Guy; O'Day Steven J; Boasberg Peter D; Stern Stacey L; Ye Xing; Morton Donald L
Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4549-54.
2002: Essner Richard; Chung Mathew H; Bleicher Richard; Hsueh Eddy; Wanek Leslie; Morton Donald L
Prognostic implications of thick (>or=4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy.
Annals of surgical oncology 2002;9(8):754-61.
2002: Morton Donald L; Hsueh Eddy C; Essner Richard; Foshag Leland J; O'Day Steven J; Bilchik Anton; Gupta Rishab K; Hoon Dave S B; Ravindranath Mepur; Nizze J Anne; Gammon Guy; Wanek Leslie A; Wang He-Jing; Elashoff Robert M
Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.
Annals of surgery 2002;236(4):438-48; discussion 448-9.
2002: Perez Carlos A; Ravindranath Mepur H; Soh Daniel; Gonzales Alexandra; Ye Wei; Morton Donald L
Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
Cancer journal (Sudbury, Mass.) 2002;8(5):384-94.
2002: Ravindranath Mepur H; Wood Thomas F; Soh Daniel; Gonzales Alexandra; Muthugounder Sakunthala; Perez Carlos; Morton Donald L; Bilchik Anton J
Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM.
Cryobiology 2002;45(1):10-21.
2002: DiFronzo L Andrew; Gupta Rishab K; Essner Richard; Foshag Leland J; O'Day Steven J; Wanek Leslie A; Stern Stacey L; Morton Donald L
Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on Cancer stage II melanoma patients receiving adjuvant polyvalent vaccine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3242-8.
2002: Tsioulias George J; Wood Thomas F; Spirt Mitchell; Morton Donald L; Bilchik Anton J
A novel lymphatic mapping technique to improve localization and staging of early colon cancer during laparoscopic colectomy.
The American surgeon 2002;68(7):561-5.
2002: Hsueh Eddy C; Essner Richard; Foshag Leland J; Ye Wei; Morton Donald L
Active immunotherapy by reinduction with a polyvalent allogeneic cell vaccine correlates with improved survival in recurrent metastatic melanoma.
Annals of surgical oncology 2002;9(5):486-92.
2002: Wood Thomas F; Nora Dean T; Morton Donald L; Turner Roderick R; Rangel Decio; Hutchinson William; Bilchik Anton J
One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2002;6(3):322-9; discussion 229-30.
2002: Bilchik A J; Nora D; Tollenaar R A E M; van de Velde C J H; Wood T; Turner R; Morton D L; Hoon D S B
Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis.
European journal of cancer (Oxford, England : 1990) 2002;38(7):977-85.
2002: Chung Mathew H; Gupta Rishab K; Bilchik Anton J; Ye Wei; Yee Reynold; Morton Donald L
Preoperative serum TA90-IC as an adjunct to serum CA 19-9 in the diagnosis of pancreatic malignancy: a pilot study.
Current surgery 2002;59(2):194-8.
2002: Litvak David A; Wood Thomas F; Tsioulias George J; Chung Mathew; Chawla Sant P; Foshag Leland J; Morton Donald L; Ramming Kenneth P; Bilchik Anton J
Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases.
Annals of surgical oncology 2002;9(2):148-55.
2002: Chung Mathew H; Gupta Rishab K; Essner Richard; Ye Wei; Yee Reynold; Morton Donald L
Serum TA90 immune complex assay can predict outcome after resection of thick (> or =4 mm) primary melanoma and sentinel lymphadenectomy.
Annals of surgical oncology 2002;9(2):120-6.
2002: Perez Carlos A; Ravindranath Mepur H; Gupta Rishab K; Tollenaar Rob A E M; van de Velde Cornelius J; Wood Thomas F; Soh Daniel; Morton Donald L; Bilchik Anton J
Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancer.
Cancer journal (Sudbury, Mass.) 2002;8(1):55-61.
2001: Bilchik A J; Saha S; Tsioulias G J; Wood T F; Morton D L
Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms.
Annals of surgical oncology 2001;8(9 Suppl):82S-85S.
2001: Morton D L
Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present, and future.
Annals of surgical oncology 2001;8(9 Suppl):22S-28S.
2001: Wood T F; DiFronzo L A; Rose D M; Haigh P I; Stern S L; Wanek L; Essner R; Morton D L
Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival?
Annals of surgical oncology 2001;8(8):658-62.
2001: Tsioulias G J; Wood T F; Chung M H; Morton D L; Bilchik A
Diagnostic laparoscopy and laparoscopic ultrasonography optimize the staging and resectability of intraabdominal neoplasms.
Surgical endoscopy 2001;15(9):1016-9.
2001: Haigh P I; Lucci A; Turner R R; Bostick P J; Krasne D L; Stern S L; Morton D L
Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma.
Cancer 2001;92(3):535-41.
2001: Rose D M; Essner R; Hughes T M; Tang P C; Bilchik A; Wanek L A; Thompson J F; Morton D L
Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience.
Archives of surgery (Chicago, Ill. : 1960) 2001;136(8):950-5.
2001: Taback B; Fujiwara Y; Wang H J; Foshag L J; Morton D L; Hoon D S
Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
Cancer research 2001;61(15):5723-6.
2001: Wood T F; Spirt M; Rangel D; Shen P; Tsioulias G J; Morton D L; Bilchik A J
Lymphatic mapping improves staging during laparoscopic colectomy for cancer.
Surgical endoscopy 2001;15(7):715-9.
2001: Habal N; Gupta R K; Bilchik A J; Yee R; Leopoldo Z; Ye W; Elashoff R M; Morton D L
CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer.
Annals of surgical oncology 2001;8(5):389-401.
2001: Ravindranath M H; Gonzales A; Soh D; Nishimoto K; Tam W Y; Bilchik A; Morton D L; O'Day S
Interleukin-2 binds to ganglioside GD(1b).
Biochemical and biophysical research communications 2001;283(2):369-73.
2001: Tsioulias G J; Gupta R K; Tisman G; Hsueh E C; Essner R; Wanek L A; Morton D L
Serum TA90 antigen-antibody complex as a surrogate marker for the efficacy of a polyvalent allogeneic whole-cell vaccine (CancerVax) in melanoma.
Annals of surgical oncology 2001;8(3):198-203.
2001: DiFronzo L A; Wanek L A; Morton D L
Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up.
Cancer 2001;91(8):1520-4.
2001: Nakayama T; Taback B; Turner R; Morton D L; Hoon D S
Molecular clonality of in-transit melanoma metastasis.
The American journal of pathology 2001;158(4):1371-8.
2001: Wood T F; Saha S; Morton D L; Tsioulias G J; Rangel D; Hutchinson W; Foshag L J; Bilchik A J
Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques.
Annals of surgical oncology 2001;8(2):150-7.
2001: Kelley M C; Gupta R K; Hsueh E C; Yee R; Stern S; Morton D L
Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1176-82.
2001: Bilchik A J; Saha S; Wiese D; Stonecypher J A; Wood T F; Sostrin S; Turner R R; Wang H J; Morton D L; Hoon D S
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1128-36.
2001: Taback B; Morton D L; O'Day S J; Nguyen D H; Nakayama T; Hoon D S
The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2001;158():78-92.
2000: Wood T F; Tsioulias G J; Morton D L; Rangel D; Hutchinson W; Foshag L J; Turner R R; Bilchik A J
Focused examination of sentinel lymph nodes upstages early colorectal carcinoma.
The American surgeon 2000;66(11):998-1003.
2000: Ravindranath M H; Shen P; Habal N; Soh D; Nishimoto K; Gonzales A; Tam W Y; Bilchik A; Morton D L
Does human melanoma express carcinoembryonic antigen?
Anticancer research 2000;20(5A):3083-92.
2000: Shen P; Wanek L A; Morton D L
Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas?
Annals of surgical oncology 2000;7(8):554-9; discussion 560-1.
2000: Tsioulias G J; Wood T F; Morton D L; Bilchik A J
Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms.
Archives of surgery (Chicago, Ill. : 1960) 2000;135(8):926-32.
2000: Chan A D; Essner R; Wanek L A; Morton D L
Judging the therapeutic value of lymph node dissections for melanoma.
Journal of the American College of Surgeons 2000;191(1):16-22; discussion 22-3.
2000: Habal N; Gupta R K; Bilchik A J; Johnson T; Morton D L
TA90-IC, a new marker for advanced colon cancer.
Annals of surgical oncology 2000;7(5):352-6.
2000: Bilchik A J; Wood T F; Allegra D; Tsioulias G J; Chung M; Rose D M; Ramming K P; Morton D L
Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm.
Archives of surgery (Chicago, Ill. : 1960) 2000;135(6):657-62; discussion 662-4.
2000: Ravindranath M H; Gonzales A M; Nishimoto K; Tam W Y; Soh D; Morton D L
Immunology of gangliosides.
Indian journal of experimental biology 2000;38(4):301-12.
2000: Nakayama T; Taback B; Nguyen D H; Chi D D; Morton D L; Fujiwara Y; Hoon D S
Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients.
Annals of the New York Academy of Sciences 2000;906():87-98.
2000: Hsueh E C; Gupta R K; Yee R; Leopoldo Z C; Qi K; Morton D L
Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?
Annals of surgical oncology 2000;7(3):232-8.
2000: Hoon D S; Bostick P; Kuo C; Okamoto T; Wang H J; Elashoff R; Morton D L
Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.
Cancer research 2000;60(8):2253-7.
2000: Chu K U; Ravindranath M H; Gonzales A; Nishimoto K; Tam W Y; Soh D; Bilchik A; Katopodis N; Morton D L
Gangliosides as targets for immunotherapy for pancreatic adenocarcinoma.
Cancer 2000;88(8):1828-36.
2000: Shen P; Conforti A M; Essner R; Cochran A J; Turner R R; Morton D L
Is the node of Cloquet the sentinel node for the iliac/obturator node group?
Cancer journal (Sudbury, Mass.) 2000;6(2):93-7.
2000: Shen P; Guenther J M; Wanek L A; Morton D L
Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?
Annals of surgical oncology 2000;7(2):114-9.
2000: Essner R; Bostick P J; Glass E C; Foshag L J; Haigh P I; Wang H J; Morton D L
Standardized probe-directed sentinel node dissection in melanoma.
Surgery 2000;127(1):26-31.
2000: Essner R; Huynh Y; Nguyen T; Morton D L; Hoon D S
Functional interleukin 4 receptor and interleukin 2 receptor common gamma-chain on human non-small cell lung cancers: novel targets for immune therapy.
The Journal of thoracic and cardiovascular surgery 2000;119(1):10-20.
2000: Chan A D; Morton D L
Sentinel node detection in malignant melanoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2000;157():161-77.
1999: Bilchik A J; Rose D M; Allegra D P; Bostick P J; Hsueh E; Morton D L
Radiofrequency ablation: a minimally invasive technique with multiple applications.
The cancer journal from Scientific American 1999;5(6):356-61.
1999: Haigh P I; Difronzo L A; Gammon G; Morton D L
Vaccine therapy for patients with melanoma.
Oncology (Williston Park, N.Y.) 1999;13(11):1561-74; discussion 1574 passim.
1999: Morton D L; Ollila D W
Critical review of the sentinel node hypothesis.
Surgery 1999;126(5):815-9.
1999: DiFronzo L A; Wanek L A; Elashoff R; Morton D L
Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma.
Annals of surgical oncology 1999;6(7):705-11.
1999: Haigh P I; Essner R; Wardlaw J C; Stern S L; Morton D L
Long-term survival after complete resection of melanoma metastatic to the adrenal gland.
Annals of surgical oncology 1999;6(7):633-9.
1999: Morton D L; Thompson J F; Essner R; Elashoff R; Stern S L; Nieweg O E; Roses D F; Karakousis C P; Mozzillo N; Reintgen D; Wang H J; Glass E C; Cochran A J
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.
Annals of surgery 1999;230(4):453-63; discussion 463-5.
1999: Bostick P J; Morton D L; Turner R R; Huynh K T; Wang H J; Elashoff R; Essner R; Hoon D S
Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3238-44.
1999: O'Day S J; Gammon G; Boasberg P D; Martin M A; Kristedja T S; Guo M; Stern S; Edwards S; Fournier P; Weisberg M; Cannon M; Fawzy N W; Johnson T D; Essner R; Foshag L J; Morton D L
Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2752-61.
1999: Ollila D W; Hsueh E C; Stern S L; Morton D L
Metastasectomy for recurrent stage IV melanoma.
Journal of surgical oncology 1999;71(4):209-13.
1999: Morton D L; Chan A D
Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care?
Journal of the American College of Surgeons 1999;189(2):214-23.
1999: Essner R; Conforti A; Kelley M C; Wanek L; Stern S; Glass E; Morton D L
Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma.
Annals of surgical oncology 1999;6(5):442-9.
1999: Lucci A; Turner R R; Morton D L
Carbon dye as an adjunct to isosulfan blue dye for sentinel lymph node dissection.
Surgery 1999;126(1):48-53.
1999: Hsueh E C; Nathanson L; Foshag L J; Essner R; Nizze J A; Stern S L; Morton D L
Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases.
Cancer 1999;85(10):2160-9.
1999: Fujiwara Y; Chi D D; Wang H; Keleman P; Morton D L; Turner R; Hoon D S
Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.
Cancer research 1999;59(7):1567-71.
1999: Ollila D W; Foshag L J; Essner R; Stern S L; Morton D L
Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma.
Annals of surgical oncology 1999;6(2):150-4.
1999: Kelemen P R; Wanek L A; Morton D L
Lymph node biopsy does not impair survival after therapeutic dissection for palpable melanoma metastases.
Annals of surgical oncology 1999;6(2):139-43.
1999: Hsueh E C; Lucci A; Qi K; Morton D L
Survival of patients with melanoma of the lower extremity decreases with distance from the trunk.
Cancer 1999;85(2):383-8.
1998: Ollila D W; Stern S L; Morton D L
Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma.
Journal of surgical oncology 1998;69(4):206-11.
1998: Chan A D; Morton D L
Active immunotherapy with allogeneic tumor cell vaccines: present status.
Seminars in oncology 1998;25(6):611-22.
1998: Okamoto T; Irie R F; Fujii S; Huang S K; Nizze A J; Morton D L; Hoon D S
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.
The Journal of investigative dermatology 1998;111(6):1034-9.
1998: Bilchik A J; Giuliano A; Essner R; Bostick P; Kelemen P; Foshag L J; Sostrin S; Turner R R; Morton D L
Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms.
The cancer journal from Scientific American 1998;4(6):351-8.
1998: Hsueh E C; Famatiga E; Gupta R K; Qi K; Morton D L
Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survival.
Annals of surgical oncology 1998;5(7):595-602.
1998: Huang S K; Okamoto T; Morton D L; Hoon D S
Antibody responses to melanoma/melanocyte autoantigens in melanoma patients.
The Journal of investigative dermatology 1998;111(4):662-7.
1998: Kelley M C; Jones R C; Gupta R K; Yee R; Stern S; Wanek L; Morton D L
Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma.
Cancer 1998;83(7):1355-61.
1998: Hsueh E C; Gupta R K; Qi K; Morton D L
Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):2913-20.
1998: Hsueh E C; Gupta R K; Glass E C; Yee R; Qi K; Morton D L
Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic melanoma.
Journal of the American College of Surgeons 1998;187(2):191-7.
1998: Glass E C; Essner R; Morton D L
Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(7):1185-90.
1998: Ollila D W; Kelley M C; Gammon G; Morton D L
Overview of melanoma vaccines: active specific immunotherapy for melanoma patients.
Seminars in surgical oncology 1998;14(4):328-36.
1998: Kelley M C; Ollila D W; Morton D L
Lymphatic mapping and sentinel lymphadenectomy for melanoma.
Seminars in surgical oncology 1998;14(4):283-90.
1998: Hoon D S; Okamoto T; Wang H J; Elashoff R; Nizze A J; Foshag L J; Gammon G; Morton D L
Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1430-7.
1998: Kuo C T; Bostick P J; Irie R F; Morton D L; Conrad A J; Hoon D S
Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):411-8.
1998: Lucci A; Cho W I; Han T Y; Giuliano A E; Morton D L; Cabot M C
Glucosylceramide: a marker for multiple-drug resistant cancers.
Anticancer research 1998;18(1B):475-80.
1998: Ravindranath M H; Kelley M C; Jones R C; Amiri A A; Bauer P M; Morton D L
Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in mice.
International journal of cancer. Journal international du cancer 1998;75(1):117-24.
1997: Morton D L
Sentinel lymphadenectomy for patients with clinical stage I melanoma.
Journal of surgical oncology 1997;66(4):267-9.
1997: Hsueh E C; Gupta R K; Qi K; Yee R; Leopoldo Z C; Morton D L
TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
The cancer journal from Scientific American 1997;3(6):364-70.
1997: Morton D L
Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard care or clinical investigation?
The cancer journal from Scientific American 1997;3(6):328-30.
1997: Conforti A M; Ollila D W; Kelley M C; Gammon G; Morton D L
Update on active specific immunotherapy with melanoma vaccines.
Journal of surgical oncology 1997;66(1):55-64.
1997: Ravindranath M H; Amiri A A; Bauer P M; Kelley M C; Essner R; Morton D L
Endothelial-selectin ligands sialyl Lewis(x) and sialyl Lewis(a) are differentiation antigens immunogenic in human melanoma.
Cancer 1997;79(9):1686-97.
1997: Sarantou T; Chi D D; Garrison D A; Conrad A J; Schmid P; Morton D L; Hoon D S
Melanoma-associated antigens as messenger RNA detection markers for melanoma.
Cancer research 1997;57(7):1371-6.
1997: Ravindranath M H; Bauer P M; Amiri A A; Miri S M; Kelley M C; Jones R C; Morton D L
Cellular cancer vaccine induces delayed-type hypersensitivity reaction and augments antibody response to tumor-associated carbohydrate antigens (sialyl Le(a), sialyl Le(x), GD3 and GM2) better than soluble lysate cancer vaccine.
Anti-cancer drugs 1997;8(3):217-24.
1997: Dale P S; Foshag L J; Wanek L A; Morton D L
Metastasis of primary melanoma to two separate lymph node basins: prognostic significance.
Annals of surgical oncology 1997;4(1):13-8.
1997: Ravindranath M H; Morton D L
Immunogenicity of membrane-bound gangliosides in viable whole-cell vaccines.
Cancer investigation 1997;15(5):491-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Donald Morton

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Donald Morton (preview)

All Publications